Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL352178 | 0.93 | — | — | |
| SCHEMBL2270433 | 0.89 | ALDH1A1 (0.40) | CYP1A2CYP2A6 | |
| SCHEMBL10973920 | 0.86 | — | — | |
| SCHEMBL385879 | 0.85 | METAP2 (0.38) | CYP2A6 | |
| SCHEMBL20774140 | 0.84 | HPRT1 (0.50) | CYP1A2CYP2A6 | |
| SCHEMBL3783406 | 0.83 | ALDH1A1 (0.46) | CYP1A2CYP2A6 | |
| SCHEMBL152508 | 0.82 | CYP1A2 (0.33) | CYP1A2 | |
| SCHEMBL6783338 | 0.82 | — | — | |
| SCHEMBL20773990 | 0.82 | ALDH1A1 (0.43) | CYP1A2 | |
| SCHEMBL20774105 | 0.82 | ALDH1A1 (0.41) | CYP1A2CYP2A6 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2352801-B1 | ELECTROACTIVE MATERIALS | DU PONT (US) | 2017-06-21 | — | — | EP | disclosed |
| US-9099653-B2 | Electroactive materials | E I DU PONT DE NEMOURS AND COMPANY (US) | 2015-08-04 | — | — | US | disclosed |
| EP-2352801-A2 | ELECTROACTIVE MATERIALS | E. I. du Pont de Nemours and Company (US) | 2011-08-10 | — | — | EP | disclosed |
| US-20100187506-A1 | ELECTROACTIVE MATERIALS | LG CHEM, LTD. (KR) | 2010-07-29 | — | — | US | disclosed |
| WO-2010065497-A2 | ELECTROACTIVE MATERIALS | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 2010-06-10 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100187506-A1 | ELECTROACTIVE MATERIALS | ARL1, ITGA1, ITGB1 | CYP1A2 469/4885CYP2A6 2277/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.